Medasense Biometrics Ltd.

Medasense Biometrics Ltd. is an Israel-based medtech company specializing in AI-driven nociception monitoring to quantify pain response and optimize analgesia in clinical settings. The company's proprietary NOL® technology analyzes physiological signals to help clinicians personalize pain treatment, reduce opioid use, and prevent postoperative pain. The FDA-authorized PMD-200™ platform is designed for critical care applications including anesthesia and surgery, providing real-time visualization of patient pain levels. Medasense's pipeline includes NOLedge™, which extends pain insights to clinic and home care settings. The company addresses the global pain management crisis through non-invasive quantification of pain responses, supporting healthcare providers with clinical evidence, education via Medasense Academy, and collaborations with major OEMs including Medtronic, Philips, Mindray, and Nihon Kohden. Applications span intraoperative monitoring, postoperative pain prevention, and emergency care settings.